- iCrowdNewswire
  • Spain
  • Brazil
  • Russia
  • France
  • Germany
  • China
  • Korea
  • Japan

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Mar 14, 2018 8:40 AM ET

Alzheimer’s disease and Diagnostic Market Expected to Reach USD 12 Billion by the end of the Forecasted Period 2018 to 2022

iCrowdNewswire - Mar 14, 2018

The Worldwide Alzheimer’s Disease Diagnostic Market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. Factors such rising efforts on research and development by the players to treat Alzheimer’s disease and the introduction of the blockbuster drugs into the market to cure the disease will drive the growth of the market. The Global Alzheimer’s Disease Diagnostic Market is expected to grow with CAGR of ~10% during the forecasted period.

The market has been segmented on the basis of type which comprises of early-onset alzheimer’s, late-onset alzheimer’s, familial Alzheimer’s disease and others. On the basis of diagnostic tests; market is segmented into genetic testing, neurological exam, mini-mental state exam (MMSE), brain imaging and others. On the basis of end users; market is segmented into clinics, hospitals, diagnostic centers and others.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/2149 .

The Global Alzheimer’s Disease Diagnostic Market Key Players:

The major participants of this market are: Eli Lilly and Company (UK), TauRx (Republic of Singapore), Alector LLC (US), Accera, Inc. (US), Treventis Corporation (US), Neuro-Bio Ltd (UK), Cognition Therapeutics Inc. (US) and others.

Regional Analysis of Global Alzheimer’s Disease Diagnostic Market:

North America holds the largest market share in global Alzheimer’s disease diagnostic in 2015. The North America Alzheimer’s disease diagnostic market is expected to reach USD 12 Million by the end of the forecast period.

Europe is the second-largest market for Alzheimer’s disease diagnostic. Asia Pacific is expected to be fastest growing region of the Alzheimer’s disease diagnostic market.

Top 5 Reasons to Buy the Reports:

Company profiling with detailed strategies, financials, and recent development activities

Market Strategic Business Influence Data

Market Research Future recommendations in key business segments based on the market estimations

Market share analysis of the top industry players

Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis

Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/2149 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Contact Information:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

View Related News >